Page 163 | Certara

Brochure

IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success

In vitro-in vivo correlation (IVIVC) is an important, predictive mathematical tool in drug development, used…

CertaraNovember 8, 2016

Blog

Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug

Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…

CertaraOctober 21, 2016

Press Release

Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan

PRINCETON, NJ – Oct. 13, 2016 – Certara, the leading provider of decision support technology…

CertaraOctober 13, 2016

Press Release

Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’

PRINCETON, NJ – Oct. 6, 2016 – Certara announces that Kelley Kendle, president of Synchrogenix,…

CertaraOctober 6, 2016

Publication

Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models

CertaraOctober 5, 2016

Publication

A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion

Metritis is a frequent problem in postpartum dairy cows. Intrauterine therapy with the antimicrobial oxytetracycline…

CertaraOctober 1, 2016

Publication

Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains

CertaraOctober 1, 2016

Blog

FDA’s New Module 1 is a Bridge to eCTD 4

Editor’s note: Jason Rock served as Project Lead for the HL7 RCRIM Expert Working Group…

CertaraSeptember 13, 2016

Blog

Arming Adherence-based Drug Development with Pharmacometrics

The time is right to explore how sensor-enabled digital adherence monitoring systems can benefit patients,…

CertaraSeptember 12, 2016

Brochure

Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists

Phoenix NLME is the PK/PD modeling software that is user-friendly and easy-to-learn. Built from the…

CertaraSeptember 12, 2016

IVIVC Software – Achieving Regulatory, Formulation and Manufacturing Success

Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug

Certara Establishes Phoenix PK/PD Centers of Excellence in China and Japan

Kelley Kendle, President of Certara’s Synchrogenix Division, Named to DBT ‘Top 40 Under 40’

Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models

A Study to Examine the Relationship Between Metritis Severity and Depletion of Oxytetracycline in Plasma and Milk after Intrauterine Infusion

Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains

FDA’s New Module 1 is a Bridge to eCTD 4

Arming Adherence-based Drug Development with Pharmacometrics

Phoenix NLME, The Modern PK/PD Modeling Software for Today’s Scientists

Newsletter sign up

Quick links

Solutions

Contact